BROWN ADVISORY INC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 48 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
BROWN ADVISORY INC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$184,706
+7.2%
15,0290.0%0.00%
Q4 2022$172,232
+207.6%
15,0290.0%0.00%
Q3 2022$56,000
-37.1%
15,0290.0%0.00%
Q2 2022$89,000
-6.3%
15,0290.0%0.00%
Q1 2022$95,000
+61.0%
15,0290.0%0.00%
Q4 2021$59,000
-19.2%
15,0290.0%0.00%
Q3 2021$73,000
-24.0%
15,0290.0%0.00%
Q2 2021$96,000
+2.1%
15,0290.0%0.00%
Q1 2021$94,000
-9.6%
15,0290.0%0.00%
Q4 2020$104,000
+73.3%
15,0290.0%0.00%
Q3 2020$60,000
+20.0%
15,0290.0%0.00%
Q2 2020$50,000
+56.2%
15,0290.0%0.00%
Q1 2020$32,000
-31.9%
15,0290.0%0.00%
Q4 2019$47,000
-30.9%
15,0290.0%0.00%
Q3 2019$68,000
-25.3%
15,0290.0%0.00%
Q2 2019$91,000
-12.5%
15,0290.0%0.00%
Q1 2019$104,000
+79.3%
15,0290.0%0.00%
Q4 2018$58,000
-31.8%
15,029
-6.2%
0.00%
Q3 2018$85,000
-13.3%
16,029
-20.0%
0.00%
Q2 2018$98,000
-39.1%
20,0290.0%0.00%
-100.0%
Q1 2018$161,000
-21.5%
20,0290.0%0.00%0.0%
Q4 2017$205,000
-29.6%
20,0290.0%0.00%0.0%
Q3 2017$291,00020,0290.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2019
NameSharesValueWeighting ↓
Newtyn Management, LLC 362,335$3,714,0000.57%
Rubric Capital Management LP 410,244$4,205,0000.52%
WITTENBERG INVESTMENT MANAGEMENT, INC. 83,811$859,0000.37%
Yakira Capital Management, Inc. 83,969$861,0000.28%
KEMPNER CAPITAL MANAGEMENT INC. 14,898$153,0000.10%
STONEBRIDGE CAPITAL MANAGEMENT INC 18,550$200,0000.07%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 66,498$681,0000.05%
Cannell & Co. 75,467$774,0000.03%
Trexquant Investment LP 21,347$219,0000.02%
PDT Partners, LLC 58,004$595,0000.02%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders